The evolution of assays for immuno-oncology research
Drug Discovery World
FEBRUARY 15, 2023
Another widely available commercial model is the cell-line derived xenograft (CDX) 9 that involves inoculation of fast-growing tumour cell lines into immunodeficient mice for various applications including pharmacokinetics, efficacy of cell killing, and studying tumour metastasis by in vivo imaging.
52 
Let's personalize your content